107 results
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... • Dulaglutide (Trulicity ... Weekly injection (Ozempic ... GLP1 #Receptor #Agonists
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Exenatide ER) Weekly Ozempic ... Semaglutide) Weekly Trulicity ... Daily GLP-1 Agonists ... #GLP1 #Agonists
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
1 Medications: Ozempic ... Trulicib (semaglutide ... my experience, Ozempic ... and Trulicity are ... #Ozempic #Trulicib
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
- PPAR gamma agonist ... AGENTS • GLP-1 agonists ... - Dulaglutide (Trulicity
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... only) oral GLP1 agonist ... the injection Ozempic ... titration schedule as Ozempic ... GLP1 agonists are
Classification of Adrenergic Receptor Agonists (sympathomymetics)

#Adrenergic #Receptor #Agonists #sympathomymetics #Classification #Pharmacology
Adrenergic Receptor Agonists ... Adrenergic #Receptor #Agonists
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
mu-opioid receptor agonist ... displacing full agonists ... As a partial agonist ... However, full agonists ... As a partial agonist
Adrenergic Receptors - Agonists and Antagonists
 • Alpha-1 Vascular
 • Alpha-2 Presynaptic
 • Beta-1 Heart
 •
Adrenergic Receptors - Agonists ... Adrenergic #Receptors #Agonists
Third Generation Antipsychotics: Mechanisms and Side Effects
(Atypical Anti-Psychotics) Example: Aripiprazole
Dopamine D2 Receptor Partial Agonist
 • Binds
Receptor Partial Agonist ... Serotonin 1A Partial Agonist ... to D2-receptor agonism
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
short-acting β2-agonists ... long-acting β2-agonists